Tech Company Financing Transactions
Microbiotica Funding Round
Microbiotica closed a $67 million Series B funding round on 3/27/2022. Backers included Flerie Invest, Tencent Holdings and British Patient Capital.
Transaction Overview
Company Name
Announced On
3/27/2022
Transaction Type
Venture Equity
Amount
$67,000,000
Round
Series B
Investors
Flerie Invest (Lead Investor)
Tencent Holdings (Lead Investor)
Proceeds Purpose
The company intends to use the proceeds to progress its two lead oral Live Bacterial Therapeutics (LBTs), MB097 and MB310 to Phase 1b clinical studies. The funds will also be used to expand Microbiotica's discovery pipeline of biomarkers and LBTs in new disease areas.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Chesterford Research Park Little Chesterford
Cambridge, CB10 1XL
UK
Cambridge, CB10 1XL
UK
Phone
Website
Email Address
Overview
The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the potential to be a major new therapeutic modality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Romanos
Chief Marketing Officer
Ron Carter
Chief Operating Officer
Tim Sharpington
Chief Scientific Officer
Trevor Lawley
VP - Operations
Ro Gardner
Browse more venture capital transactions:
Prev: 3/27/2022: Linktree venture capital transaction
Next: 3/27/2022: Justpoint venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs